No description available.

A tabarana Salminus hilarii (Characiformes) é uma espécie reofílica de grande importância ecológica na Bacia do Alto Tietê (São Paulo/SP, Brasil). Atualmente esta espécie sofre com a poluição (industrial e doméstica) e a construção de barragens na região, o que pode prejudicar o comportamento migratório reprodutivo das espécies reofílicas, bloqueando a reprodução. O presente estudo tem como objetivo analisar os mecanismos fisiológicos envolvidos no controle endógeno da reprodução Salminus hilarii, analisando-se o eixo hipófise-gônadas. Adicionalmente, buscou-se avaliar se o bloqueio da migração reprodutiva (parcial ou total) altera o funcionamento deste eixo. Os animais foram coletados no ambiente natural (Bacia do Alto Tietê), na saída da Barragem da Barragem de Ponte Nova e na Piscicultura de Ponte Nova (Salesópolis/SP) durante o período de abril de 2004 e agosto de 2006. As análises macro e microscópicas das gônadas e os valores de IGS mostraram que o período reprodutivo da tabarana ocorreu entre os meses de outubro a fevereiro. As análises macroscópicas e microscópicas dos ovários e dos testículos permitiram classificar o desenvolvimento ovariano em 4 estádios: repouso, maturação inicial, maturação avançada (cativeiro), maduro (ambiente natural) e regressão/esgotado e o desenvolvimento testicular em 3 estádio: repouso, maduro e regressão. O desenvolvimento oocitário da tabarana é do tipo sincrônico em grupo e a desova é total; os testículos são do tipo tubular anastomosado e espermatogonial irrestrito. Foram identificados 5 tipos celulares no interior dos ovários: oogônias, oócito perinucleolar, oócito cortical-alveolar, oócito vitelogênico e oócito maduro, além de estruturas derivadas desse desenvolvimento, os folículos pós-ovulatórios e os oócitos atrésicos. Identificou-se também 6 tipos celulares no interior dos testículos: espermatogônias, espermatócitos, espermátides, espermatozóides, células de Sertoli e células de Leydig. A hipófise de S. hilarii é composta de dois tecidos: a adeno-hipófise (tecido glandular endócrino) e a neuro-hipófise (origem nervosa). Adicionalmente, foi verificado que a adeno-hipófise é subdividida em: “rostral pars distalis" (RPD), “proximal pars distalis" (PPD) e “pars intermedia" (PI). Seis tipos celulares foram identificados na adeno-hipófise: as células produtoras de prolactina (PRL) e as células produtoras de hormônio adrenocorticotrópico (ACTH) foram identificadas na região da RPD; as células produtoras de hormônio de crescimento (GH) e as células produtoras de gonadotropinas (GtHs) estão situadas na região da PPD; as células produtoras de melanotropina (MSH) e as células produtoras de somatolactina (SL) estão presentes na PI. As células PRL não apresentam variações ao longo do ciclo reprodutivo da tabarana, no entanto, as células produtoras de GH diminuem a porcentagem de imunomarcação com o avanço do ciclo reprodutivo. Já as células produtoras de SL aumentam a porcentagem de imunomarcação com o desenvolvimento das gônadas. Adicionalmente, foi verificada a presença de duas gonadotropinas na região da adeno-hipófise, o hormônio folículo estimulante (FSH) e o hormônio luteinizante (LH). Em relação ao perfil plasmático dos esteróides gonadais, foi verificado que o estradiol aumenta com o avanço do ciclo reprodutivo, diminuindo do estádio maduro para o estádio regressão/esgotado (ambiente natural). No cativeiro ocorreu um aumento da concentração de estradiol do estádio repouso até o estádio maturação média, diminuindo logo em seguida nos estádios maturação avançada e regressão/esgotado. A concentração de testosterona eleva-se com o avanço da maturação gonadal, atingindo os valores máximos no estádio maduro (ambiente natural) e maturação avançada (cativeiro). Paralelamente, o estradiol apresentou-se alto somente na maturação média (cativeiro) e maduro (ambiente natural), evidenciando uma relação entre esses dois hormônios. Valores mais elevados de 17α-hidroxiprogesterona no cativeiro sugerem uma deficiência na conversão deste esteróide para17α, 20β-dihidroxy-4-pregnen-3-one, considerado como o hormônio indutor da maturação final e ovulação na maioria dos teleósteos. Os resultados encontrados evidenciam que o bloqueio da migração altera a fisiologia do eixo hipófise-gônadas em Salminus hilarii. / The tabarana Salminus hilarii (Characiformes) is a reofilic species of great ecological importance in the Region of the Alto Tietê Basin (São Paulo/SP, Brazil). This fish reaches greater sizes in this Basin and as a carnivorous species, which occupies the top of the alimentary chain. Nowadays, the Tietê Basin is affected by pollution (industrial and domestic) and dam constructions in the upper reaches of the river, hindering the reproductive migratory behavior of the reofilic species. When the “piracema" fish migration is obstructed, the reproduction fails, making evident, that the dam construction in the Brazilian rivers causes great impacts in the life cycle of the reofilic teleost. The aim of this study was analyze the physiological mechanisms involved in Salminus hilarii reproduction, analyzing the pituitary-gonads axis and additionally, to evaluate if the migration impediment (partial or total) modifies this axis physiology, and consequently the endogenous control of tabarana reproduction. From April 2004 to August.2006, the animals were collected in the natural environment (upper Tietê Basin), in the water exit of Ponte Nova Dam (Department of Water and Electric Energy) and in the Ponte Nova Dam Fishfarm (Salesópolis/SP). The microscopical analyses of the gonads and analyses of the gonadossomatic Index showed that the reproductive period of the tabarana occurred between October and February. The macroscopic and microscopical analyses of the ovaries and testis allowed to classify the ovarial development in 4 stages: resting, initial maturation, advanced maturation (captivity) or maturity (natural environmental) and regression/spawned, and the testis development in 3 stages: resting, mature and regression. The tabarana oocyte development is group-synchronous and the spawning is total. The anastomosing tubular testis and unrestricted spermatogonia were observed. Five cellular types in the interior of the ovaries were identified: oogonia, perinucleolar oocyte, cortical alveolar oocyte, vitellogenic oocyte and ripe oocyte, and beyond structures derived from this evelopment, the post-ovulatory follicles and the atretic oocyte. In the testis, 6 cellular types were identified: spermatogonia, spermatocytes, spermatids, spermatozoa, Sertoli cell and Leydig cell. S. hilarii pituitary is composed of two different tissues: adenohypophysis (endocrine tissue) and neurohypophysis (nervous origin). Additionally, it was verified that adenohypophysis is subdivided in: “rostral pars distalis" (RPD), “proximal pars distalis" (PPD) and “pars intermedia" (PI). Six cellular types were identified in adenohypophysis: prolactin cells (PRL) and adenocorticotropin cells (ACTH) have been identified in the RPD region; growth hormone cells (GH) and the gonadotropinas cells (GtHs) were situated in the PPD region; melanotropin cells (MSH) and somatolactin cells (SL) were present in the PI. PRL cells did not present variations throughout the reproductive cycle of the tabarana. However, the GH reaction showed a decrease in the cells stained percentage with the advance of the reproductive cycle. Also the SL cells increased the stained percentage along the gonads development. Additionally, the presence of two gonadotropins in the region of adenohypophysis, the follicle-stimulating hormone (FSH) and the luteinizing hormone (LH) was identified. The plasma levels of sex steroids showed that estradiol increased with the advance of the reproductive cycle, diminishing from the mature to the regression/spawning stage (natural environmental). In captivity an increase of the estradiol concentration from the resting to the medium maturation stage was observed, diminishing immediately afterwards in advanced maturation and regression/spawning stage. The testosterone concentration increased with the advance of the gonadal maturation, reaching the maximum values in the mature stage (natural environmental) and advanced maturation stage (captivity). On the other hand, estradiol was high only in the medium maturation (captivity) and ripe stage (natural environmental), evidencing an interdependence between these two steroids. The progestagene analyses showed that, in all maturation stages, 17α OHP levels were higher in captivity than in the natural environment, suggesting that the conversion of this steroid to 17α20β DHP (MIS) is affected in impaired environments, and that the conversion enzyme (20β desidrogenase) fails when migration is blocked. The results allow to conclude that the migration impairment change negatively the pituitary-gonads axis in S. hilarii.

As sirtuínas 1-7 (SIRT) constituem uma família altamente conservada de desacetilases de histonas que, de modo geral, participam da regulação da longevidade em diversos organismos, modulando a resposta celular frente ao stress oxidativo e promovendo mecanismo de reparo de DNA, parada do ciclo celular, estabilidade telomérica, senescência e apoptose celulares. O envolvimento das SIRTs no processo tumorigênico tem sido bastante investigado, contudo ainda não existe descrição do estudo desses genes nos adenomas hipofisários. O objetivo desse estudo foi avaliar a expressão gênica das SIRT1-7 nos somatotropinomas e adenomas hipofisários clinicamente não funcionantes (ACNF) e sua relação com o tamanho e a invasividade do tumor. A expressão das sirtuínas foi ainda correlacionada à expressão dos marcadores de senescência CDKN1A (p21) e CDKN2A (p16) e do proto-oncogene PTTG (pituitary tumor transforming gene). Foram selecionados 68 pacientes, 37 somatotropinomas e 31 portadores de ACNF. Desses casos, 33 apresentavam tumores invasivos e 35 eram não invasivos. A quantificação do RNAm das SIRT1-7, CDKN1A, CDKN2A e PTTG foi realizada nas amostras tumorais pela técnica de PCR em tempo real utilizando o método de quantificação relativa 2-??Ct. A hiperexpressão da SIRT1 foi observada em 86,5% dos somatotropinomas versus 41,9% dos ACNF (P < 0.01), não sendo observada perda de expressão desse gene. A SIRT3 foi mais hipoexpressa nos ACNF em relação aos somatotropinomas (77,4% e 40,5%, respectivamente; P < 0.01). A SIRT4 foi hipo e hiperexpressa, respectivamente, em 45,2% e 12,9% dos ACNF e 16,2% e 24,3% dos somatotropinomas (P=0.03). A hipoexpressão da SIRT7 também foi maior nos ACNF (67,7%) versus somatotropinomas (32,4%; P=0.01) e, para ambos os subtipos, o percentual de casos apresentando hiperexpressão desse RNAm foi baixo. O padrão de expressão das SIRT2 e 5 não diferiu entre os subtipos tumorais e não se mostrou alterado em relação ao pool de hipófises normais. Não foi observada diferença estatisticamente significante na expressão dos genes das sirtuínas entre os grupos de tumores invasivos e não invasivos. Contudo, a expressão das SIRT1 e 3 foi relacionada ao tamanho tumoral; nos casos com hiperexpressão da SIRT1 a média do maior diâmetro tumoral foi 2.4 ± 1.1 enquanto nos pacientes com expressão normal foi de 3.3 ± 1.3 (P < 0.01). Já os casos com perda de expressão da SIRT3 apresentaram tumores maiores (3.1 ± 1.2) em relação aos casos com expressão normal (2.2 ± 1.1; P < 0.01). A expressão de todas as SIRTs apresentou correlação positiva moderada (SIRT1-5,7) ou forte (SIRT6) com a expressão do CDKN1A. Uma correlação positiva foi observada também em relação a expressão do CDKN2A. Contudo, essa foi fraca e presente apenas para as SIRTs 3-5. Em relação ao PTTG, foi observado apenas uma fraca correlação com a expressão da SIRT1 e SIRT3. Em conclusão, esses resultados sugerem que a hiperexpressão de SIRT1 e a hipoexpressão das SIRTs 3, 4 e 7 podem estar relacionadas ao processo tumorigênico nos somatotropinomas e ACNFs, respectivamente e, em especial as SIRT1 e 3, ao controle da proliferação celular nesses adenomas / Sirtuins 1-7 (SIRT) are a highly conserved family of histone deacetylases. In general, these proteins are involved in the regulation of longevity in several organisms, modulating the cellular response to oxidative stress. SIRTs can also regulate DNA repair, telomeric stability, cell senescence and apoptosis. Due to their functions, there is a growing interest in the role of sirtuins in tumorigenesis. However, these genes were not investigated in pituitary tumors so far. In this study, SIRT1-7 gene expression was evaluated in somatotropinomas and nonfunctioning pituitary adenomas (NFPA) and related to tumor size and invasiveness. SIRT1-7 expression was also correlated with cellular senescence markers CDKN1A (p21) e CDKN2A (p16) and with the proto-oncogene PTTG (pituitary tumor transforming gene). Sixty-eight patients were selected, 37 with somatotropinomas and 31 with NFPA. Tumor invasion was observed in 33 patients. SIRT1-7, CDKN1A, CDKN2A and PTTG mRNA levels was evaluated from pituitary tumor samples by the real-time PCR using 2-??Ct relative quantification. Pronounced differences in SIRT1, 3, 4 and 7 expressions were identified between somatotropinomas and NFPA. Overexpression of SIRT1 was observed in 86.5% of somatotropinomas versus 41.9% of NFPA (P < 0.01) whereas underexpression was not detected. SIRT3 was more underexpressed in NFPA than somatotropinomas (77.4% and 40.5%, respectively, P < 0.01). SIRT4 was under and overexpressed, respectively, in 45.2% and 12.9% of NFPA and 16.2% and 24.3% of somatotropinomas (P=0.03). SIRT7 underexpression was also higher in NFPAs (67.7%) versus somatotropinomas (32.4%; P=0.01) with few cases showing overexpression. SIRT2 and 5 expressions did not differ between tumors subtypes and was not altered in relation to the normal pituitary gland pool. No statistically significant difference was observed in the expression of these genes between invasive and non-invasive tumor groups. However, SIRT1 and 3 expressions were related to tumor size. Mean of the largest tumor diameter was 2.4 ± 1.1 and 3.3 ± 1.3 (P < 0.01) in adenomas with SIRT1 over- and normal expression, respectively. On the other hand, cases with SIRT3 underepression exhibited larger tumors (3.1 ± 1.2) compared to cases with SIRT3 normal expression (2.2 ± 1.1, P < 0.01). Moderated (SIRT1-5.7) or strong (SIRT6) positive correlation was observed between sirtuins and CDKN1A expression. A weak correlation was observed with respect to CDKN2A expression and SIRTs 3-5. Regarding PTTG mRNA, only a weak correlation with SIRT1 and SIRT3 expression was observed. In conclusion, these results suggest that overexpression of SIRT1 and underexpression of SIRTs 3, 4 and 7 could be related to the tumorigenic process in somatotropinomas and NFPAs, respectively. SIRT1 and 3 could also play a role in control of pituitary adenomas cell proliferation

As sirtuínas 1-7 (SIRT) constituem uma família altamente conservada de desacetilases de histonas que, de modo geral, participam da regulação da longevidade em diversos organismos, modulando a resposta celular frente ao stress oxidativo e promovendo mecanismo de reparo de DNA, parada do ciclo celular, estabilidade telomérica, senescência e apoptose celulares. O envolvimento das SIRTs no processo tumorigênico tem sido bastante investigado, contudo ainda não existe descrição do estudo desses genes nos adenomas hipofisários. O objetivo desse estudo foi avaliar a expressão gênica das SIRT1-7 nos somatotropinomas e adenomas hipofisários clinicamente não funcionantes (ACNF) e sua relação com o tamanho e a invasividade do tumor. A expressão das sirtuínas foi ainda correlacionada à expressão dos marcadores de senescência CDKN1A (p21) e CDKN2A (p16) e do proto-oncogene PTTG (pituitary tumor transforming gene). Foram selecionados 68 pacientes, 37 somatotropinomas e 31 portadores de ACNF. Desses casos, 33 apresentavam tumores invasivos e 35 eram não invasivos. A quantificação do RNAm das SIRT1-7, CDKN1A, CDKN2A e PTTG foi realizada nas amostras tumorais pela técnica de PCR em tempo real utilizando o método de quantificação relativa 2-??Ct. A hiperexpressão da SIRT1 foi observada em 86,5% dos somatotropinomas versus 41,9% dos ACNF (P < 0.01), não sendo observada perda de expressão desse gene. A SIRT3 foi mais hipoexpressa nos ACNF em relação aos somatotropinomas (77,4% e 40,5%, respectivamente; P < 0.01). A SIRT4 foi hipo e hiperexpressa, respectivamente, em 45,2% e 12,9% dos ACNF e 16,2% e 24,3% dos somatotropinomas (P=0.03). A hipoexpressão da SIRT7 também foi maior nos ACNF (67,7%) versus somatotropinomas (32,4%; P=0.01) e, para ambos os subtipos, o percentual de casos apresentando hiperexpressão desse RNAm foi baixo. O padrão de expressão das SIRT2 e 5 não diferiu entre os subtipos tumorais e não se mostrou alterado em relação ao pool de hipófises normais. Não foi observada diferença estatisticamente significante na expressão dos genes das sirtuínas entre os grupos de tumores invasivos e não invasivos. Contudo, a expressão das SIRT1 e 3 foi relacionada ao tamanho tumoral; nos casos com hiperexpressão da SIRT1 a média do maior diâmetro tumoral foi 2.4 ± 1.1 enquanto nos pacientes com expressão normal foi de 3.3 ± 1.3 (P < 0.01). Já os casos com perda de expressão da SIRT3 apresentaram tumores maiores (3.1 ± 1.2) em relação aos casos com expressão normal (2.2 ± 1.1; P < 0.01). A expressão de todas as SIRTs apresentou correlação positiva moderada (SIRT1-5,7) ou forte (SIRT6) com a expressão do CDKN1A. Uma correlação positiva foi observada também em relação a expressão do CDKN2A. Contudo, essa foi fraca e presente apenas para as SIRTs 3-5. Em relação ao PTTG, foi observado apenas uma fraca correlação com a expressão da SIRT1 e SIRT3. Em conclusão, esses resultados sugerem que a hiperexpressão de SIRT1 e a hipoexpressão das SIRTs 3, 4 e 7 podem estar relacionadas ao processo tumorigênico nos somatotropinomas e ACNFs, respectivamente e, em especial as SIRT1 e 3, ao controle da proliferação celular nesses adenomas / Sirtuins 1-7 (SIRT) are a highly conserved family of histone deacetylases. In general, these proteins are involved in the regulation of longevity in several organisms, modulating the cellular response to oxidative stress. SIRTs can also regulate DNA repair, telomeric stability, cell senescence and apoptosis. Due to their functions, there is a growing interest in the role of sirtuins in tumorigenesis. However, these genes were not investigated in pituitary tumors so far. In this study, SIRT1-7 gene expression was evaluated in somatotropinomas and nonfunctioning pituitary adenomas (NFPA) and related to tumor size and invasiveness. SIRT1-7 expression was also correlated with cellular senescence markers CDKN1A (p21) e CDKN2A (p16) and with the proto-oncogene PTTG (pituitary tumor transforming gene). Sixty-eight patients were selected, 37 with somatotropinomas and 31 with NFPA. Tumor invasion was observed in 33 patients. SIRT1-7, CDKN1A, CDKN2A and PTTG mRNA levels was evaluated from pituitary tumor samples by the real-time PCR using 2-??Ct relative quantification. Pronounced differences in SIRT1, 3, 4 and 7 expressions were identified between somatotropinomas and NFPA. Overexpression of SIRT1 was observed in 86.5% of somatotropinomas versus 41.9% of NFPA (P < 0.01) whereas underexpression was not detected. SIRT3 was more underexpressed in NFPA than somatotropinomas (77.4% and 40.5%, respectively, P < 0.01). SIRT4 was under and overexpressed, respectively, in 45.2% and 12.9% of NFPA and 16.2% and 24.3% of somatotropinomas (P=0.03). SIRT7 underexpression was also higher in NFPAs (67.7%) versus somatotropinomas (32.4%; P=0.01) with few cases showing overexpression. SIRT2 and 5 expressions did not differ between tumors subtypes and was not altered in relation to the normal pituitary gland pool. No statistically significant difference was observed in the expression of these genes between invasive and non-invasive tumor groups. However, SIRT1 and 3 expressions were related to tumor size. Mean of the largest tumor diameter was 2.4 ± 1.1 and 3.3 ± 1.3 (P < 0.01) in adenomas with SIRT1 over- and normal expression, respectively. On the other hand, cases with SIRT3 underepression exhibited larger tumors (3.1 ± 1.2) compared to cases with SIRT3 normal expression (2.2 ± 1.1, P < 0.01). Moderated (SIRT1-5.7) or strong (SIRT6) positive correlation was observed between sirtuins and CDKN1A expression. A weak correlation was observed with respect to CDKN2A expression and SIRTs 3-5. Regarding PTTG mRNA, only a weak correlation with SIRT1 and SIRT3 expression was observed. In conclusion, these results suggest that overexpression of SIRT1 and underexpression of SIRTs 3, 4 and 7 could be related to the tumorigenic process in somatotropinomas and NFPAs, respectively. SIRT1 and 3 could also play a role in control of pituitary adenomas cell proliferation

A tabarana Salminus hilarii (Characiformes) é uma espécie reofílica de grande importância ecológica na Bacia do Alto Tietê (São Paulo/SP, Brasil). Atualmente esta espécie sofre com a poluição (industrial e doméstica) e a construção de barragens na região, o que pode prejudicar o comportamento migratório reprodutivo das espécies reofílicas, bloqueando a reprodução. O presente estudo tem como objetivo analisar os mecanismos fisiológicos envolvidos no controle endógeno da reprodução Salminus hilarii, analisando-se o eixo hipófise-gônadas. Adicionalmente, buscou-se avaliar se o bloqueio da migração reprodutiva (parcial ou total) altera o funcionamento deste eixo. Os animais foram coletados no ambiente natural (Bacia do Alto Tietê), na saída da Barragem da Barragem de Ponte Nova e na Piscicultura de Ponte Nova (Salesópolis/SP) durante o período de abril de 2004 e agosto de 2006. As análises macro e microscópicas das gônadas e os valores de IGS mostraram que o período reprodutivo da tabarana ocorreu entre os meses de outubro a fevereiro. As análises macroscópicas e microscópicas dos ovários e dos testículos permitiram classificar o desenvolvimento ovariano em 4 estádios: repouso, maturação inicial, maturação avançada (cativeiro), maduro (ambiente natural) e regressão/esgotado e o desenvolvimento testicular em 3 estádio: repouso, maduro e regressão. O desenvolvimento oocitário da tabarana é do tipo sincrônico em grupo e a desova é total; os testículos são do tipo tubular anastomosado e espermatogonial irrestrito. Foram identificados 5 tipos celulares no interior dos ovários: oogônias, oócito perinucleolar, oócito cortical-alveolar, oócito vitelogênico e oócito maduro, além de estruturas derivadas desse desenvolvimento, os folículos pós-ovulatórios e os oócitos atrésicos. Identificou-se também 6 tipos celulares no interior dos testículos: espermatogônias, espermatócitos, espermátides, espermatozóides, células de Sertoli e células de Leydig. A hipófise de S. hilarii é composta de dois tecidos: a adeno-hipófise (tecido glandular endócrino) e a neuro-hipófise (origem nervosa). Adicionalmente, foi verificado que a adeno-hipófise é subdividida em: “rostral pars distalis” (RPD), “proximal pars distalis” (PPD) e “pars intermedia” (PI). Seis tipos celulares foram identificados na adeno-hipófise: as células produtoras de prolactina (PRL) e as células produtoras de hormônio adrenocorticotrópico (ACTH) foram identificadas na região da RPD; as células produtoras de hormônio de crescimento (GH) e as células produtoras de gonadotropinas (GtHs) estão situadas na região da PPD; as células produtoras de melanotropina (MSH) e as células produtoras de somatolactina (SL) estão presentes na PI. As células PRL não apresentam variações ao longo do ciclo reprodutivo da tabarana, no entanto, as células produtoras de GH diminuem a porcentagem de imunomarcação com o avanço do ciclo reprodutivo. Já as células produtoras de SL aumentam a porcentagem de imunomarcação com o desenvolvimento das gônadas. Adicionalmente, foi verificada a presença de duas gonadotropinas na região da adeno-hipófise, o hormônio folículo estimulante (FSH) e o hormônio luteinizante (LH). Em relação ao perfil plasmático dos esteróides gonadais, foi verificado que o estradiol aumenta com o avanço do ciclo reprodutivo, diminuindo do estádio maduro para o estádio regressão/esgotado (ambiente natural). No cativeiro ocorreu um aumento da concentração de estradiol do estádio repouso até o estádio maturação média, diminuindo logo em seguida nos estádios maturação avançada e regressão/esgotado. A concentração de testosterona eleva-se com o avanço da maturação gonadal, atingindo os valores máximos no estádio maduro (ambiente natural) e maturação avançada (cativeiro). Paralelamente, o estradiol apresentou-se alto somente na maturação média (cativeiro) e maduro (ambiente natural), evidenciando uma relação entre esses dois hormônios. Valores mais elevados de 17&#945;-hidroxiprogesterona no cativeiro sugerem uma deficiência na conversão deste esteróide para17&#945;, 20&#946;-dihidroxy-4-pregnen-3-one, considerado como o hormônio indutor da maturação final e ovulação na maioria dos teleósteos. Os resultados encontrados evidenciam que o bloqueio da migração altera a fisiologia do eixo hipófise-gônadas em Salminus hilarii. / The tabarana Salminus hilarii (Characiformes) is a reofilic species of great ecological importance in the Region of the Alto Tietê Basin (São Paulo/SP, Brazil). This fish reaches greater sizes in this Basin and as a carnivorous species, which occupies the top of the alimentary chain. Nowadays, the Tietê Basin is affected by pollution (industrial and domestic) and dam constructions in the upper reaches of the river, hindering the reproductive migratory behavior of the reofilic species. When the “piracema” fish migration is obstructed, the reproduction fails, making evident, that the dam construction in the Brazilian rivers causes great impacts in the life cycle of the reofilic teleost. The aim of this study was analyze the physiological mechanisms involved in Salminus hilarii reproduction, analyzing the pituitary-gonads axis and additionally, to evaluate if the migration impediment (partial or total) modifies this axis physiology, and consequently the endogenous control of tabarana reproduction. From April 2004 to August.2006, the animals were collected in the natural environment (upper Tietê Basin), in the water exit of Ponte Nova Dam (Department of Water and Electric Energy) and in the Ponte Nova Dam Fishfarm (Salesópolis/SP). The microscopical analyses of the gonads and analyses of the gonadossomatic Index showed that the reproductive period of the tabarana occurred between October and February. The macroscopic and microscopical analyses of the ovaries and testis allowed to classify the ovarial development in 4 stages: resting, initial maturation, advanced maturation (captivity) or maturity (natural environmental) and regression/spawned, and the testis development in 3 stages: resting, mature and regression. The tabarana oocyte development is group-synchronous and the spawning is total. The anastomosing tubular testis and unrestricted spermatogonia were observed. Five cellular types in the interior of the ovaries were identified: oogonia, perinucleolar oocyte, cortical alveolar oocyte, vitellogenic oocyte and ripe oocyte, and beyond structures derived from this evelopment, the post-ovulatory follicles and the atretic oocyte. In the testis, 6 cellular types were identified: spermatogonia, spermatocytes, spermatids, spermatozoa, Sertoli cell and Leydig cell. S. hilarii pituitary is composed of two different tissues: adenohypophysis (endocrine tissue) and neurohypophysis (nervous origin). Additionally, it was verified that adenohypophysis is subdivided in: “rostral pars distalis” (RPD), “proximal pars distalis” (PPD) and “pars intermedia” (PI). Six cellular types were identified in adenohypophysis: prolactin cells (PRL) and adenocorticotropin cells (ACTH) have been identified in the RPD region; growth hormone cells (GH) and the gonadotropinas cells (GtHs) were situated in the PPD region; melanotropin cells (MSH) and somatolactin cells (SL) were present in the PI. PRL cells did not present variations throughout the reproductive cycle of the tabarana. However, the GH reaction showed a decrease in the cells stained percentage with the advance of the reproductive cycle. Also the SL cells increased the stained percentage along the gonads development. Additionally, the presence of two gonadotropins in the region of adenohypophysis, the follicle-stimulating hormone (FSH) and the luteinizing hormone (LH) was identified. The plasma levels of sex steroids showed that estradiol increased with the advance of the reproductive cycle, diminishing from the mature to the regression/spawning stage (natural environmental). In captivity an increase of the estradiol concentration from the resting to the medium maturation stage was observed, diminishing immediately afterwards in advanced maturation and regression/spawning stage. The testosterone concentration increased with the advance of the gonadal maturation, reaching the maximum values in the mature stage (natural environmental) and advanced maturation stage (captivity). On the other hand, estradiol was high only in the medium maturation (captivity) and ripe stage (natural environmental), evidencing an interdependence between these two steroids. The progestagene analyses showed that, in all maturation stages, 17&#945; OHP levels were higher in captivity than in the natural environment, suggesting that the conversion of this steroid to 17&#945;20&#946; DHP (MIS) is affected in impaired environments, and that the conversion enzyme (20&#946; desidrogenase) fails when migration is blocked. The results allow to conclude that the migration impairment change negatively the pituitary-gonads axis in S. hilarii.

Gene transfer to the brain is a promising therapeutic strategy for a variety of neurodegenerative disorders including Parkinson‟s disease (PD). PD is the second most common neurodegenerative disease. Although many drugs have been developed and introduced into the market to provide symptomatic treatment, there is still no cure for PD. Glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for injured nigrostriatal dopamine neurons and is currently being evaluated as a potential treatment for PD. Gene therapy allows localized, long-term and stable transgene expression after a single intervention to obtain a therapeutic effect. Regulatable promoters for transgene expression furthermore allow optimizing GDNF concentration to avoid undesirable biological activity and clinical side effects. In the first part of the study, an autoregulatory tetracycline-inducible recombinant adeno-associated viral vector (rAAV-pTetbidiON) utilizing the rtTAM2 reverse tetracycline transactivator (rAAV-rtTAM2) was used to conditionally express the human GDNF cDNA. Eight weeks after a single intrastriatal injection of the rAAV-rtTAM2-GDNF vector encapsidated into AAV serotype 1 capsids (rAAV2/1), the GDNF protein level was respectively 15 fold higherand undistinguishable from the endogenous level in doxycycline(Dox) treated and untreated animals. However, a residual GDNF expression in the uninduced animals was evidenced by a sensitive immunohistochemical staining. As compared to rAAV2/1-rtTAM2-GDNF, the rAAV2/1-rtTAM2-WPRE-GDNF vector harboring a woodchuck hepatitis post-transcriptional regulatory element, which increases and stabilizes the transgene transcript, expressed a similar concentration of GDNF in the induced state but a basal level ~2.5-fold higher than the endogenous striatal level. However, the distribution of GDNF in the striatum in induced state was more widespread using the rAAV2/1-rtTAM2-WPRE-GDNF vector as compared to rAAV2/1-rtTAM2- GDNF. As a proof for biological activity, for both vectors, downregulation of tyrosine hydroxylase (TH) was evidenced in dopaminergic terminals of Dox-treated but not untreated animals. In the second part of my study, functional (behavioural) and neurochemical changes mediated by delayed intrastriatal GDNF gene delivery in the partial Parkinson‟s disease rat model were investigated. The rAAV2/1-rtTAM2-WPRE-GDNF vector (3.5 108 viral genomes) was administered unilaterally in the rat striatum 5 weeks after intrastriatal injection of 6-hydroxydopamine (6-OHDA) which produces a partial and progressive lesion of the nigro-striatal dopaminergic pathway. Rats were treated with Dox or untreated from the day of vector injection until sacrifice at 4 or 14 weeks (continuous treatment). A sub-group was Dox-treated for 7 weeks (temporary treatment) then untreated until 14 weeks. In the absence of Dox, the GDNF tissue concentration was found to be equivalent to the endogenous level in 6-OHDA-lesioned rats. In the presence of Dox, it was ~10-fold higher. Dox-dependent behavioral improvements were demonstrated 4 weeks post-vector injection. At later time points, spontaneous partial recovery was observed in all rats, but no further improvement was found in Dox-treated animals. Moreover GDNF gene delivery only transiently improved dopaminergic function. Over the long term, TH was more abundant, but not functional, and the increase was lost when GDNF gene expression was switched off. The third part of my study consisted in the evaluation of the respective dose-range of therapeutical and undesirable effects of GDNF. Functional effects appeared after delivery of 3.5 108 viral particles which produced 200-300 pg/mg protein of GDNF in the lesioned rat striatum (see above). In order to evaluate the viral dose producing undesirable effects, we compared two different doses of vector: 3.5x108 and 4.4x109 viral genome. In the low dose group, the GDNF concentration in the striatum was ~300 pg/mg protein in the Dox-treated animals and equivalent to the endogenous level in untreated animals (~20 pg/mg protein). In contrast, in the high dose group, GDNF levels reached ~1200 pg/mg protein in induced animals but up to ~300 pg/mg protein in uniduced animals. In the low dose group, Dox-dependent downregulation of TH but no asymetrical behaviour was evidenced. In the high dose group, TH downregulation was observed in both Dox+ and Dox-rats. In addition, amphetamine-induced rotational behaviour was evidenced in Dox+ but not in Dox-rats. These data suggest that low doses of virus are sufficient to induce therapeutically-relevant but not undesirable functional effects of GDNF. Nevertheless,a neurochemical effect of GDNF (TH down-regulation) did appear at low dose. In order to understand the GDNF-induced motor asymmetry, we investigated the anatomical pattern of TH down regulation in striatum. Strikingly, there was a greater loss of TH labeling in striosomes than in the surrounding matrix. Receptors which are known to be differentially expressed in the striosomes i.e. µ-opioid receptor(MOR-1) and N-methyl-D-aspartic acid (NMDA) receptor 1 (NR1) as compared to the matrix were analyzed in the high-dose group of animals. MOR-1 was not affected by GDNF gene delivery. In contrast, NR1 was down regulated. The potential relationship between TH and NR1 down-regulation as well as other previously described neurochemical effects of GDNF (as enhancement of DA release and metabolism, of DA neurons excitability or of TH phosphorylation) and behavioural asymmetry remains to be clarified. As summary, our data suggest that behavioural and neurochemical effects of striatal delivery of GDNF can be controlled by Dox by using the autoregulatory rAAV2/1-TetON- GDNF vector, provided the dose range of gene delivery is carefully adjusted. / Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished

La myopathie myotubulaire est une maladie musculaire congénitale très sévère. Le laboratoire d’accueil a démontré que les échantillons de muscle de patients atteints de cette maladie ainsi que le modèle murin présentent une surexpression de DNM2, alors que sa réduction par croisement génétique améliore les signes cliniques et histologiques de la maladie. Le but de ce travail consistait à développer, tester et valider des composés injectables qui ciblent DNM2 et diminuent son niveau. Deux approches thérapeutiques ont été développées l’une basée sur l’utilisation de virus adéno-associés (AAV) exprimant des shRNA, l’autre sur les oligonucleotides antisens (ASO). L’injection des vecteurs AAV-shDnm2 ou bien les ASO-Dnm2 pouvait corriger les défauts histologiques et fonctionnels des muscles des souris myopathes.Les résultats obtenus montrent le potentiel thérapeutique de la réduction de DNM2, et présente une nouvelle approche pour le traitement de la myopathie myotubulaire. / Myotubular myopathy is a severe muscle disease. We previously have shown that muscle specimens of both patients and the mouse model presented an overexpression of DNM2, while its genetic reduction prevents the development of the muscle phenotypes. The aim of this work was to develop, test and validate deliverable compounds. Two therapeutic approaches were used. Injection of antisense oligonucleotide or adeno-associated virus expressing shRNA restores a normal lifespan with improved muscle structure and function of the myopathic mice. These results demonstrate that therapeutic potential of reduction of DNM2 level and provides an attractive therapeutic strategy that could be applied to treat myotubular myopathy.

L’expression d’un transgène grâce au vecteur AAV offre une perspective thérapeutique très prometteuse dans le traitement de maladies monogéniques. Malheureusement, il apparait souvent que des réponses immunes contre le vecteur et le transgène conduisent à un rejet des cellules transduites ainsi qu’à la mise en place d’une mémoire immunitaire spécifique empêchant un nouveau traitement ultérieur. Avec la perspective d’éviter tout rejet immun des cellules transduites, j’ai développé deux approches distinctes. D’une part, nous avons développé un système dans lequel l’expression du transgène est déstabilisée dans les cellules présentatrices de l’antigène grâce à l’ajout de cibles du miRNA 142.3p qui est spécifiquement exprimé dans le système hématopoïétique. Nous avons ainsi montré que la réponse immunitaire contre le transgène était favorisée par la transduction des cellules présentatrices de l’antigène par le vecteur, conduisant à la présentation directe du produit du transgène. En comparant l’initiation des réponses immunes contre plusieurs transgènes modèles, nous avons montré que la réponse immune dirigée contre le transgène pouvait être contrôlée mais que celle-ci dépendait étroitement de l’immunogénicité intrinsèque du transgène en question, c'est-à-dire de la présence d’épitopes reconnus par des lymphocytes T CD4 auxiliaires ainsi que par les lymphocytes B. Une autre approche a concerné l’utilisation de lymphocytes T régulateurs exprimant le facteur de transcription Foxp3 (Treg) et plus particulièrement l’étude de leur mode d’induction in vivo. La présence de Treg conférant une tolérance immunitaire spécifique du transgène a été décrite dans diverses situations et les Treg induits à partir de CD4+ matures (pTreg/iTreg) semblent avoir un potentiel thérapeutique important. Cependant, la population précise de lymphocytes CD4+ à même d’être convertie en Treg n’avait pas été identifiée auparavant. Au cours de mes travaux, analysant la capacité de conversion de cellules naïves, mémoires ou de récents émigrants thymiques, j’ai mis en évidence que le potentiel de conversion des lymphocytes CD4 naïfs issus de souris âgées était diminué et que ceci était dû à une caractéristique intrinsèque des lymphocytes T CD4+ provenant de telles souris. Enfin, nous avons montré que cette faible capacité de conversion des lymphocytes CD4 naïfs en Treg était associée à un rejet de greffe accru dans un modèle de transplantation de peau, montrant que la sénescence peut impacter négativement des protocoles d’induction de tolérance faisant appel à l’induction de Treg en périphérie. / Transgene expression through AAVvectors offers a very promising therapeutic perspective in the treatment of monogenic disorders. Unfortunately, it often appears that the immune responses against the transgene and the vector lead to the rejection of transduced cells and to an establishment of a specific immune memory preventing further processing. With a view to avoid immune rejection of transduced cells, I developed two distinct approaches.First, we have developed a system where the transgene expression is destabilized in the antigen presenting cells by addition of the target miRNA 142.3p which is specifically expressed in the hematopoietic system. We have shown that the immune response against the transgene was favored by transduction of antigen presenting cells with the vector, leading to the direct presentation of the transgene product. Comparing the initiation of immune responses against more transgenes models, we showed that the immune response against the transgene could be controlled but it depended greatly on the intrinsic immunogenicity of the transgène: the presence of epitopes recognized by T helper cells and CD4 by B lymphocytes. Another approach has involved the use of regulatory T cells expressing the transcription factor Foxp3 ( Treg ) and more specifically the study of their mode of induction in vivo. The presence of Treg conferring transgene -specific immune tolerance has been described in various situations and induced Treg from CD4 + mature ( pTreg / iTreg ) appear to have a significant therapeutic potential . However, the precise population of CD4 + lymphocytes capable of being converted into Treg was not identified previously. During my work, analyzing the conversion capacity naive, memory cells or thymic recent emigrants, I highlighted that the potential of conversion of naive CD4 lymphocytes from old mice was decreased and this was due to an intrinsic defect of CD4 + T cells from such mice. Finally, we showed that low conversion ability of CD4 naive Treg was associated with an increased graft rejection in a model of skin transplantation, showing that senescence may negatively impact protocols of tolerance induction using induction of Treg in the periphery.

One of the major challenges facing medicine and drug discovery is the large number of genetic diseases caused by inherited mutations leading to a toxic gain-of-function, or loss-of-function of the disease protein. Microbiology offered a new glimpse of hope to address those disorders with the adaptation of the bacterial CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) defense system as a genome editing tool. Cas9 is a unique CRISPR-associated endonuclease protein that can be easily programmed with an RNA [a single-guide RNA (sgRNA)] that is complementary to nearly any DNA locus. Cas9 creates a double-stranded break (DSB) that can be exploited to knock out toxic genes or replenish therapeutic expression levels of essential proteins. In addition to a matching sgRNA sequence, Cas9 requires the presence of a short signature sequence [a protospacer adjacent motif (PAM)] flanking the target locus. Over the past few years, several Cas9-based therapeutic platforms have emerged to correct DNA mutations in a wide range of mammalian cell lines, ex vivo, and in vivo by adapting recombinant adeno-associated virus (rAAV). However, most of the applications of Cas9 in the field have been limited to Streptococcus pyogenes (SpyCas9), which, in its wild-type form, suffers from inaccurate editing at off-target sites. It is also difficult to deliver via an all-in-one (sgRNA+Cas9) rAAV approach due to its large size. In this thesis, I describe other Cas9 nucleases and their development as new AAV-based genome editing platforms for therapeutic editing in vivo in mouse disease models. In the first part of this thesis, I develop the all-in-one AAV strategy to deliver a Neisseria meningitidis Cas9 ortholog (Nme1Cas9) in mice to reduce the level of circulating cholesterol in blood. I also help characterize an enhanced Cas9 from another meningococcus strain (Nme2Cas9) and show that it is effective in performing editing not only in mammalian cell culture, but also in vivo by all-in-one AAV delivery. Additionally, I describe two AAV platforms that enable advanced editing modalities in vivo: 1) segmental DNA deletion by delivering two sgRNAs (along with Nme2Cas9) in one AAV, and 2) precise HDR-based repair by fitting Nme2Cas9, sgRNA and donor DNA within a single AAV capsid. Using these tools, we successfully treat two genetic disorders in mice, underscoring the importance of this powerful duo of AAV and Cas9 in gene therapy to advance novel treatment. Finally, I present preliminary data on how to use these AAV.Nme2Cas9 vectors to treat Alexander Disease, a rare progressive neurological disorder. These findings provide a platform for future application of gene editing in therapeutics.

Indiana University-Purdue University Indianapolis (IUPUI) / High-efficiency transduction of hematopoietic stem cells (HSCs) by recombinant adeno-associated virus serotype 2 (AAV2) vectors is limited by (i) inadequate expression of cellular receptor/co-receptors for AAV2; (ii) impaired intracellular trafficking and uncoating in the nucleus; (iii) failure of the genome to undergo second-strand DNA synthesis; and (iv) use of sub-optimal promoters. Systematic studies were undertaken to develop alternative strategies to achieve high-efficiency transduction of primary murine HSCs and lineage-restricted transgene expression in a bone marrow transplant model in vivo. These included the use of: (i) additional AAV serotype (AAV1, AAV7, AAV8, AAV10) vectors; (ii) self-complementary AAV (scAAV) vectors; and (iii) erythroid cell-specific promoters. scAAV1 and scAAV7 vectors containing an enhanced green-fluorescent protein (EGFP) reporter gene under the control of hematopoietic cell-specific enhancers/promoters allowed sustained transgene expression in an erythroid lineage-restricted manner in both primary and secondary transplant recipient mice. Self complementary AAV vectors containing an anti-sickling human beta-globin gene under the control of either the beta-globin gene promoter/enhancer, or the human parvovirus B19 promoter at map-unit 6 (B19p6) were tested for their efficacy in a human erythroid cell line (K562), and in primary murine hematopoietic progenitor cells (c-kit+, lin-). These studies revealed that (i) scAAV2-beta-globin vectors containing only the HS2 enhancer are more efficient than ssAAV2-beta-globin vectors containing the HS2+HS3+HS4 enhancers; (ii) scAAV-beta-globin vectors containing only the B19p6 promoter are more efficient than their counterparts containing the HS2 enhancer/beta-globin promoter; and (iii) scAAV2-B19p6-beta-globin vectors in K562 cells, and scAAV1-B19p6-beta-globin vectors in murine c-kit+, lin- cells, yield efficient expression of the beta-globin protein. These studies suggest that the combined use of scAAV serotype vectors and the B19p6 promoter may lead to expression of therapeutic levels of beta-globin gene in human erythroid cells, which has implications in the potential gene therapy of beta-thalassemia and sickle cell disease.